Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors is a research paper published in Frontiers in Bioengineering and Biotechnology (2020). On theSindex it has a DataRank of 0. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA138264
NCI NIH HHS
Grant: U01 CA212007
NCI NIH HHS
Grant: UM1 CA186691
NCI NIH HHS
Grant: UM1 CA186717
National Institutes of Health
Grant: 5U01CA212007-03
Integrating bioinformatics into multiscale models for hepatocellular carcinoma
National Institutes of Health
Grant: 5R01CA138264-13
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
Fields of Study
Keywords
Sustainable Development Goals